-
Study aim
-
Determine the Effectiveness of Local Tranexamic Acid on Reducing of intra and post external Dacryosystorhinosity hemorrhage in Patients with Primary Acquired Obstruction of Nasolacrimal Duct
-
Design
-
Phase 3 clinical trial, double-blind randomized, control group, parallel groups, sample size 126, randomization of quadruple computer blocks
-
Settings and conduct
-
This study will be conducted at the Amiralmomenin Medical Center of Rasht.After obtaining informed consent from patients, four groups of randomized blocks will be studied in two intervention and control groups.After the patient is ready for surgery,the desired solution and placebo are injected in the surgical site (0.5 ml in the posterior region, 0.5 ml in the superior and in the inferior, and 0.5 ml in the infra orbital nerve).The bleeding from the surgical site by suction blood volume assessment and surgeon satisfaction of the surgical field numerically 1: good, 2: moderate and 3: Bad evaluated in two groups.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements: patients over 50 years of age with primary and acquired obstruction of the nasolacrimal duct of the candidate for surgery dacryosisturinostomy (DCR).
Non-arrival conditions: any disturbances in coagulation tests.
-
Intervention groups
-
In the intervention group, the following combination is injected at the surgical site:
3.5 ml Bupivaine 5%, 4 ml Lidocain 2%, 0.1 Adrenalin 1/100000, 2.5 ml Tranexamic Acid
In the control group, the following combination is injected at the surgical site:
3.5ml Bupivaine 5%, 4ml Lidocain 2% , 0.1 Adrenalin 1/100000,Normal saline 0.05 ml/kg
-
Main outcome variables
-
Reduce the amount of bleeding during surgery